Health Condition 1: null- Iron deficiency anemia
Conditions
Interventions
Intervention1: Injection Ferric Carboxymaltose: As per calculated dose, not exceeding 1000 mg per infusion.usually 2 infusions per subject was required.
Control Intervention1: Ferrous sulfate tablet:
Sponsors
UCMS and GTB Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Postnatal women within 10 days of normal delivery. 2. Hb should be more than or equal to 7 gm% and less than or equal 10 gm%. 3. Peripheral smear showing microcytic hypochromic anemia or red cell indices suggestive of iron deficiency anemia (PCV <36%, MCV <80fl, MCH <27pg and MCHC <33gm/dl) with negative NESTROF test.
Exclusion criteria
Exclusion criteria: 1. Women with weight 2. Puerperal pyrexia. 3. Known drug allergy or intolerance to iron therapy. 4. History of chronic medical illness such as tuberculosis, asthma, liver diseases, kidney diseases, diabetes mellitus, hypertension, HIV infection. 5. Received other intervention for management of anemia such as blood transfusion, erythropoietin administration in last three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients achieving Hb rise 3 g/dl from baseline at 3 and 6 weeks.Timepoint: Percentage of patients achieving Hb rise 3 g/dl from baseline at 3 and 6 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Percentage of patients achieving Hb 12 g/dl at 3 and 6 weeks. - Rise in Hb from baseline to 3 and 6 weeks. - Change in red cell indices and serum iron parameters from baseline to 6 weeks. - Recording the side effects in both the groups such as dysguesia, nausea, abdominal pain, urticaria, muscle cramps, headache, nasopharyngitis, fever, infusion site burning pain, serum transaminase elevation, etc.Timepoint: 6 weeks | — |
Countries
India
Contacts
Public ContactDr Shikha
UCMS & GTB HOSPITAL
Outcome results
None listed